Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of [68Ga]BED003 for PET Imaging in Selected Oncology Indications
NCT07702292Phase 2Recruiting
- Sponsor
- Blue Earth Diagnostics
- Start
- Jun 2026
- Primary completion
- Feb 2028
- Countries
- 2
01
Overview
A Phase 2 trial of 68Ga-BED003 in colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), Invasive Lobular Carcinoma (ILC), epithelial ovarian cancer (EOC), sponsored by Blue Earth Diagnostics. Started Jun 2026; status: recruiting.
02
Drugs
68Ga-BED003
03
Conditions
colorectal cancer (CRC)gastric cancer (GC)pancreatic ductal adenocarcinoma (PDAC)Invasive Lobular Carcinoma (ILC)epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT07702292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07702292.